Positive response from Eurostars regarding Nexam

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 10, 2014 at 10:00 AM

Positive response from Eurostars regarding Nexam Chemical’s rPET project - just over SEK 3.4 million in funding grants to Nexam Chemical.

Eurostars* has approved Nexam Chemical’s rPET (recycled PET) project application. The project will run over 24 months and aims to upgrade recycled PET** with heat-activated crosslinking agents and commercializing the use of upgraded PET material. In addition to Nexam Chemical, two European partners are part of the project. Nexam Chemical’s part of the assigned funding grants from Eurostars and its local government authorities amounts to 375 000 Euro. The project is based on Nexam Chemical’s crosslinking technology. Nexam Chemical has received news that the rPET project has, by an independent international panel of experts appointed by the Eurostars Secretariat, been ranked so high that it can be financed within the member countries allocated budgets. Nexam and its two partners will now enter into a consortium agreement and as soon as this is completed, the grants funding will formally approved. In addition to Nexam Chemical, which is responsible for the management of the project, the project consists of the two partners Armacell Benelux, the world's leading producer of PET foams, and The European Van Company, a specialized parts producer of sandwich composites to the auto body industry. "We are happy to announce that our rPET project application received such high rankings by Eurostars. It is further proof of Nexam’s crosslinking technology and its effects. In this case, it concerns the improvement of performance in recycled PET, with the use of Nexam’s crosslinkers, for various applications (PET foam, PET injection molding and pressing, etc.). This would enable users to replace virgin PET with recycled PET, which is both cheaper for the user and positive for the environment. That Nexam receives just over SEK 3.4 million in grants, which is the same thing as reduced costs, over two years is positive.", says Per Morin, CEO at Nexam Chemical. The market for engineering polyesters currently amounts to approximately 2 million tons per year. Nexam works with crosslinkers to polyesters (which in addition to PET, contains PBT) and is currently collaborating with several producers and users of engineering polyesters. *Eurostars is a joint EU initiative between EUREKA and the EU's Eighth Framework Programme for Research and Technological Development (Horizon 2020). The purpose is to provide funding for applied research and development with a focus on commercialization for small- and medium-sized enterprises. **PET (poly-(ethylene terephthalate)) is a plastic that is most known for its use in bottles and advanced packaging (food and pharmaceutical packaging). The plastic is also used for the manufacture of components to e.g. household appliances, the electrical and automobile industry, and the manufacture of foam cores to e.g. composite parts and molded products. Note: This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. For more information, please contact: Lennart Holm, Chairman of the Board: +46 (0)706 30 8562 Per Palmqvist Morin, CEO, +46 (0)706 55 55 82 Nexam is a Swedish company with a world-leading technology within its area for heat-activated crosslinking of plastics and polymers. The company develops, manufactures and markets unique heat-activated crosslinkers to the plastics market. A company description and more information about the business will be found on www.nexam.se. The company’s Certified Adviser is Remium Nordic AB.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

CVS Study: GLP-1 Drugs Effective But Costly

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Layne's Chicken Fingers Expands with Brownsville Opening

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Championing Change: USTA Mid-Atlantic Gala's Impact

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Employment Law Suit Hits ABC: Alleged Wage Violations

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...